MDEpiNet’s Scientific Oversight Committee recently conducted its introductory meeting, and is now beginning to review the first round of proposals that have been submitted to it.
The committee is the convening, oversight, and facilitation body for MDEpiNet’s Working Groups. It includes a broad range of individuals, representing the scientific community (from academia and industry) and regulatory agencies (from the United States and other countries). The committee’s charter directs it to consider key aspects of the Working Group implementation plans, the alignment of objectives with the MDEpiNet mission; the practicality of any implementation plans, including access to resources, leadership, expertise and timelines for deliverables; and the impact of specific proposed deliverables.
Chaired by Jesse Berlin of Johnson and Johnson, and Gregory Pappas of the U.S. Food and Drug Administration, the committee is currently evaluating the proposals generated by the Predictable and Sustainable Implementation of National Cardiovascular Registries (PASSION) and Specific, Measurable, Achievable, Results-Oriented, Time Bound Collaboration (SMART) INFORMATICS Think Tank meetings held earlier this year. At present, there are nine projects under consideration by the Scientific Oversight Committee.
“Our intent is to take on a collaborative role and provide helpful advice to investigators on study design, implementation, and desired outcomes,” Berlin said. “The goal is to improve investigators’ chances for obtaining ongoing external funding and provide an objective scientific perspective to ensure that the proposals are aligned with MDEpiNet’s goals.
“We are not, at least for now, aiming at any kind of evaluation or approval role, in part because we’re not a funding body,” he said.